Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.
about
Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitisAntiviral therapy for genital herpes for prevention of HIV transmissionAntiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitisTherapeutic interventions for herpes simplex virus epithelial keratitisThe effects of antiviral therapy of genital herpes in HIV-infected individualsImpact of suppressive antiviral therapy on the health related quality of life of patients with recurrent genital herpes infectionAntiviral drug resistance: mechanisms and clinical implicationsFamciclovir for treatment of herpesvirus infectionsEnzyme catalyzed synthesis of some vinyl drug esters in organic medium.Diagnosis and management of viral retinitis in the acute retinal necrosis syndrome.Recent advances in antiviral therapy.Facial herpes zoster infection precipitated by surgical manipulation of the trigeminal nerve during exploration of the posterior fossa: a case report.Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study GroupPharmacokinetics of oral acyclovir in neonates and in infants: a population analysis.Novel agents for the therapy of varicella-zoster virus infections.The treatment of herpes simplex virus epithelial keratitisResistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and managementAcyclovir levels in serum and cerebrospinal fluid after oral administration of valacyclovir.Formulation and optimization of mucoadhesive nanodrug delivery system of acyclovirThe use of antiviral drugs during the neonatal periodMain adult herpes virus infections of the CNS.Novel drug delivery approaches on antiviral and antiretroviral agents.2-[4,5-Difluoro-2-(2-fluorobenzoylamino)-benzoylamino]benzoic acid, an antiviral compound with activity against acyclovir-resistant isolates of herpes simplex virus types 1 and 2.Characteristics of patients with shingles admitted to a district general hospital.Antiherpes virus-specific treatment and cognition in schizophrenia: a test-of-concept randomized double-blind placebo-controlled trialAntiviral Chemistry & Chemotherapy's current antiviral agents FactFile (2nd edition): DNA viruses.Herpes simplex keratitis: challenges in diagnosis and clinical management.Acute viral infections of the central nervous system in immunocompetent adults: diagnosis and management.Peptide inhibitors against herpes simplex virus infections.Antimicrobial Properties of Plant Essential Oils against Human Pathogens and Their Mode of Action: An Updated ReviewOcular sustained release nanoparticles containing stereoisomeric dipeptide prodrugs of acyclovir.Synthesis of novel 6-azapyrimidine acyclic nucleoside analogues and antiviral evaluation.Comparison of the novel HK-2 human renal proximal tubular cell line with the standard LLC-PK1 cell line in studying drug-induced nephrotoxicity.Study of Antiherpetic Efficiency of Phosphite of Acycloguanosine Ableto Over come the Barrier of Resistance to Acyclovir.Treatment of alpha and beta herpesvirus infections in solid organ transplant recipients.Analogues of acyclic nucleosides derived from tris-(hydroxymethyl)phosphine oxide or bis-(hydroxymethyl)phosphinic acid coupled to DNA nucleobases.Acyclovir-loaded sorbitan esters-based organogel: development and rheological characterization.Synthesis and antiviral evaluation of phosphoramidate derivatives of (E)-5-(2-bromovinyl)-2'-deoxyuridine.Variations in practice patterns: antiviral drug use in hospitalized patients with herpes infections.Valaciclovir versus aciclovir for the treatment of primary genital herpes simplex: a cost analysis.
P2860
Q24186663-14F83524-C320-4976-87FE-1E436C9CC1FEQ24234315-9F44C2FA-D6D3-4101-94DD-937D181DB079Q24235637-0C464860-F77B-4458-95BB-69D6EE6796C0Q24242791-BAA6C0D3-FF78-44FD-900E-1685CC8EFE52Q24245937-96EE9E48-113C-4119-B9B2-15D74057BB4CQ24671668-135AD8E3-1E09-47DB-9766-A083BD2323B0Q28282376-75DE123C-C886-41E6-B47E-7EAEBA83B3A6Q28293932-1F4A5E0A-C1EC-4DFE-8D9F-62D4979E17C9Q30916565-791895E7-9CCA-4C9D-9872-40052E3284A5Q33569740-7522032B-39EC-4A46-A54D-C502F669E77EQ33681664-511DD8A4-7CDA-4A9F-964D-2D3FF52E718DQ33682005-707CBD2A-BB99-46F5-A9DC-310AA1757362Q33936572-24EC813D-DC77-48EB-B4AB-97B390DD9318Q33981154-B9224347-728D-44D7-94CE-94C92FCA630AQ34074994-FC93F861-D77F-4720-A71D-401C93BBCCA4Q34145460-FEA74828-0933-40AA-B5F3-97C1070D4BFEQ34149904-9A9667E4-C8D6-4BB8-B9A6-1EC83DD5FE7BQ35166138-83150D3F-FD24-4B95-8D21-3C2DE5359278Q35646236-BFCD6B81-0EF3-450C-954F-E175A1529B26Q35789702-5065CB40-ED15-4526-BED3-691825161F90Q36233543-0929B38B-2D02-4D54-ADEE-6F1DCE604AF2Q36283306-01D28846-C012-4B4A-A149-941326587D09Q36364125-CB8053E8-9D12-4323-A0EA-924E0CCC63EAQ36612714-6FE86252-6C2E-4172-8370-0BD4CF650F89Q36940014-ABE3FCAE-5D57-435B-AA3D-9E398E83D55AQ37252268-69E6AC97-678D-4BE8-B2D7-96318E50EE9BQ37603658-22FCBB63-2C15-4D99-A8AB-4AFA822D8758Q38078826-C8A4C7E3-D271-417E-B60D-0A95A8D47F49Q38079780-193A6680-5B6A-487A-8620-ACA550D2A17EQ39089925-07C8ED77-6CD3-422A-B43C-A503DA7F67C8Q39557119-866B75AA-F614-450C-8BEC-F024371C421DQ39686917-25C6CE39-6EAB-4EBC-A00E-3C762919594AQ39691802-4B506FCC-A183-499A-91E5-D2828829FB55Q40377171-2065C848-8F4F-4B39-BE6B-3D02E6FA5E97Q40426465-787A463F-3442-4826-853B-43CEB265B3A4Q40472499-86A7C091-D7F5-4110-B9B0-A71B43681BDFQ40739149-FBD8AB91-12EF-4A53-9C37-C011DF94DC7CQ40744086-1A6F30F5-251C-457D-B690-234A1A7E5E1EQ41078028-45B7B9A3-14D1-41B0-A963-F3EAD41C19DEQ41600423-1B2FD834-E991-4E7F-8957-8D86CDE7BE67
P2860
Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.
description
1994 nî lūn-bûn
@nan
1994 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
name
Aciclovir. A reappraisal of it ...... ties and therapeutic efficacy.
@ast
Aciclovir. A reappraisal of it ...... ties and therapeutic efficacy.
@en
Aciclovir. A reappraisal of it ...... ties and therapeutic efficacy.
@nl
type
label
Aciclovir. A reappraisal of it ...... ties and therapeutic efficacy.
@ast
Aciclovir. A reappraisal of it ...... ties and therapeutic efficacy.
@en
Aciclovir. A reappraisal of it ...... ties and therapeutic efficacy.
@nl
prefLabel
Aciclovir. A reappraisal of it ...... ties and therapeutic efficacy.
@ast
Aciclovir. A reappraisal of it ...... ties and therapeutic efficacy.
@en
Aciclovir. A reappraisal of it ...... ties and therapeutic efficacy.
@nl
P2093
P1433
P1476
Aciclovir. A reappraisal of it ...... ties and therapeutic efficacy.
@en
P2093
P304
P356
10.2165/00003495-199447010-00009
P577
1994-01-01T00:00:00Z
P6179
1012977116